Dyne Therapeutics Prices $375 Million Stock Offering Amid Market Reaction
Deals·6 articles across 5 outlets
Story updated Rewritten when the story materially grows; the wire is checked every 15 minutesAbout this data
Dyne Therapeutics has priced a public offering of 18.3 million shares at $20.50 each, aiming to raise approximately $375 million. The offering includes a greenshoe option that could increase the total to $405 million.
Following the announcement, Dyne Therapeutics' stock experienced a significant decline in after-hours trading, reflecting investor concerns regarding the dilution of shares and market conditions.
Dyne Therapeutics
Sources
Every quote below is verbatim from the article it is attributed to.
SourceReports the news
“Dyne Therapeutics shares slide after pricing $375 million public offering (NASDAQ:DYN)”
Yahoo Finance — Dyne Therapeutics shares slide after pricing $375 million public offering (NASDAQ:DYN)“Dyne Therapeutics prices $375 million stock offering”
investing.com — Dyne Therapeutics prices $375 million stock offering“Dyne Therapeutics Launches 18.3M-Share Offering at $20.50; Nets ~$352M, Greenshoe to $405M”
tradingview — Dyne Therapeutics Launches 18.3M-Share Offering at $20.50; Nets ~$352M, Greenshoe to $405M
SupportCorroborates it
“Dyne Therapeutics Stock Tumbles After Hours: Here's Why”
Benzinga — Dyne Therapeutics Stock Tumbles After Hours: Here's Why“Dyne Therapeutics Announces $300 Million Proposed Public Offering of Common Stock”
quiver quantitative — Dyne Therapeutics Announces $300 Million Proposed Public Offering of Common Stock